Aehr Test Systems (AEHR)
(Delayed Data from NSDQ)
$11.47 USD
+0.17 (1.50%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $11.48 +0.01 (0.09%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for Aehr Test Systems falls in the month of May .
All items in Millions except EPS data.
5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 | 5/31/19 | |
---|---|---|---|---|---|
Sales | 65 | 51 | 17 | 22 | 21 |
Cost Of Goods | 32 | 27 | 11 | 14 | 13 |
Gross Profit | 33 | 24 | 6 | 8 | 8 |
Selling & Adminstrative & Depr. & Amort Expenses | 19 | 16 | 10 | 11 | 13 |
Income After Depreciation & Amortization | 13 | 8 | -4 | -3 | -5 |
Non-Operating Income | 0 | 2 | 2 | 0 | 0 |
Interest Expense | -1 | 0 | 0 | 0 | 0 |
Pretax Income | 15 | 10 | -2 | -3 | -5 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 15 | 9 | -2 | -3 | -5 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 15 | 9 | -2 | -3 | -5 |
Depreciation Footnote | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 | 5/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 14 | 8 | -4 | -2 | -5 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 13 | 8 | -4 | -3 | -5 |
Earnings Per Share Data | 5/31/23 | 5/31/22 | 5/31/21 | 5/31/20 | 5/31/19 |
---|---|---|---|---|---|
Average Shares | 29.22 | 27.77 | 23.46 | 22.88 | 22.39 |
Diluted EPS Before Non-Recurring Items | 0.50 | 0.32 | -0.19 | -0.04 | -0.17 |
Diluted Net EPS (GAAP) | 0.50 | 0.34 | -0.09 | -0.12 | -0.23 |
Fiscal Year end for Aehr Test Systems falls in the month of May .
All items in Millions except EPS data.
2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 | 2/28/23 | |
---|---|---|---|---|---|
Sales | 7.56 | 21.43 | 20.62 | 22.27 | 17.21 |
Cost Of Goods | 4.41 | 10.47 | 10.64 | 10.79 | 8.33 |
Gross Profit | 3.16 | 10.96 | 9.98 | 11.48 | 8.87 |
SG&A, R&D, and Dept/Amort Expenses | 5.20 | 5.49 | 5.87 | 5.84 | 5.08 |
Income After SG&A, R&D, and Dept/Amort Expenses | -2.04 | 5.47 | 4.11 | 5.64 | 3.79 |
Non-Operating Income | 0.58 | 0.64 | 0.58 | 0.00 | 0.36 |
Interest Expense | 0.00 | 0.00 | 0.00 | -1.25 | 0.00 |
Pretax Income | -1.46 | 6.11 | 4.69 | 6.12 | 4.15 |
Income Taxes | 0.01 | 0.02 | 0.02 | -0.05 | 0.02 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -1.47 | 6.09 | 4.67 | 6.17 | 4.13 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -1.47 | 6.09 | 4.67 | 6.11 | 4.13 |
Earnings Per Share Data | 2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 | 2/28/23 |
---|---|---|---|---|---|
Average Shares | 28.87 | 29.77 | 29.63 | 29.57 | 29.37 |
Diluted EPS Before Non-Recurring Items | -0.05 | 0.20 | 0.16 | 0.21 | 0.14 |
Diluted Net EPS (GAAP) | -0.05 | 0.20 | 0.16 | 0.21 | 0.14 |